ORIC Pharmaceuticals (ORIC) Short Interest
Nasdaq • ORIC • US68622P1093
As of Oct 21, 2026, ORTEX estimated 16.4% of free float sold short, 9.3 days to cover, cost to borrow 0.47%. Sign up for live short interest data.
Nasdaq • ORIC • US68622P1093
As of Oct 21, 2026, ORTEX estimated 16.4% of free float sold short, 9.3 days to cover, cost to borrow 0.47%. Sign up for live short interest data.
This page tracks how heavily ORIC Pharmaceuticals (Nasdaq:ORIC) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
ORIC Pharmaceuticals (Nasdaq: ORIC) has a market capitalization of $968.12M. Last close $9.34 (as of 2026-11-05); 52-week range $7.23 to $14.68. ORTEX data as of 2026-10-21: short interest was 16.37% of free float, 9.3 days to cover and the average cost to borrow was 0.47%. Sign up for live short interest data.